[Research funding for rare diseases in Germany]

Area of Science:

• Medical Research
• Rare Diseases
• Genetics

Background:

• Rare disease research faces challenges due to disease heterogeneity and low patient numbers.
• Effective patient stratification for individualized therapies necessitates further research and innovative diagnostics.
• Clinical translation of rare disease findings requires multicentric and international collaboration.

Purpose of the Study:

• To highlight the critical need for enhanced research in rare diseases.
• To emphasize the link between research, innovative diagnostics, and patient stratification.
• To discuss the current landscape and funding mechanisms for rare disease research in Germany and internationally.

Main Methods:

• Review of current research practices and funding structures for rare diseases.
• Analysis of the requirements for multicentric and international collaboration.
• Identification of needs for adapting funding programs and establishing interdisciplinary platforms.

Main Results:

• Research grants are vital due to low institutional financial support for rare disease studies.
• National (DFG, BMBF) and international (EU, E-Rare) programs support rare disease research.
• Existing programs require adaptation to better suit the specific needs of rare disease research.

Conclusions:

• Sustainable funding and interdisciplinary platforms are essential for rare disease research.
• International collaboration is crucial for overcoming patient number limitations and enabling clinical translation.
• Adapting funding programs and fostering knowledge sharing are key to advancing rare disease diagnostics and therapies.